Zacks.com on MSN23h
NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to BuyNovo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...
This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
WESTBOROUGH, Mass., January 09, 2025--eClinicalWorks®, the largest ambulatory cloud EHR, today announced that Clinica Medica ...
The numbers of apps for disease awareness and management are increasing and, with patients more willing to share data with HCPs, there are opportunities to better understand how conditions impact ...
It’s unacceptable to describe NPP as micro-minority in Parliament - Afenyo-Markin protests Speaker’s description 08-01-25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback